首页> 美国卫生研究院文献>Oxford Open >2079. The Relation Between Panel Reactive Antibody Assay and Cytomegalovirus Reactivation in Seropositive Solid Organ Transplantation Recipients
【2h】

2079. The Relation Between Panel Reactive Antibody Assay and Cytomegalovirus Reactivation in Seropositive Solid Organ Transplantation Recipients

机译:2079.血清反应阳性实体器官移植受者中的反应性抗体测定与巨细胞病毒激活之间的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCytomegalovirus (CMV) can lead to severe morbidities and mortalities including pneumonia in particular as well as graft dysfunction through indirect immunomodulation in solid-organ transplantation recipients. High degree of HLA mismatch is a well-known risk factor of post-transplant (Tx) CMV reactivation. Recent laboratory advances for evaluating HLA mismatch can measure existence of donor-specific antibodies for single HLA allele; however, there was little evidence whether single panel reactive Ab (PRA) assay could predict CMV reactivation in SOT recipients.
机译:背景巨细胞病毒(CMV)可以导致严重的疾病和死亡,尤其是肺炎,以及通过间接免疫调节在实体器官移植接受者中引起的移植物功能障碍。高度的HLA失配是移植后(Tx)CMV重新激活的众所周知的危险因素。评估HLA错配的最新实验室进展可以测量单个HLA等位基因的供体特异性抗体的存在。但是,几乎没有证据表明单板反应性抗体(PRA)检测是否可以预测SOT受体中的CMV激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号